In this chapter, we review general principles for developing a safe and efficacious vaccine against dengue virus, the current vaccine candidates approved and under research, and the roadmap for the introduction of a new dengue vaccine, based on the procedures, carried out by Mexico, for the licensure and eventual adoption of CYD-TDV vaccine, which concluded with Mexico becoming the first country in the world to grant licensure to a Dengue vaccine in December of 2015. Today, after decades of research, public health programs contemplate as part of the intervention to control the disease, a safe and effective vaccine against dengue. Roadmap for the Introduction of a New Dengue Vaccineīy Miguel Betancourt-Cravioto, Jorge Abelardo Falcón-Lezama andĭengue remains the most common vector-transmitted disease in the world despite enormous prevention and control efforts by endemic countries and regions. He is member of Mexico’s National Researchers System, and the Mexican Society of Public Health. Falcón-Lezama has taught postgraduate courses at National Polytechnic Institute, Juarez Autonomous University of Tabasco, and Hidalgo State Autonomous University. He has worked at Morelos State Health Services, Mexico’s Institute for Insurance and Social Services for the State Workers, as Project Coordinator on Infectious Diseases in the Direction of Global Solutions at the Carlos Slim Foundation and as a Researcher and Professor at Juarez Autonomous University of Tabasco in Mexico.ĭr. on Epidemiology at National Autonomous University of Mexico, and a Specialization course on Intelligence for National Security at Mexico’s National Institute of Public Administration. Jorge Abelardo Falcón-Lezama MD, MSc., Ph.D, obtained his Medical degree at Juárez Autonomous University of Tabasco, a Master degree on Infectious Diseases at Mexico’s National Institute of Public Health, a Ph.D.
División Académica de Ciencias de la Salud, Universidad Juárez Autónoma de Tabascoĭr.
0 kommentar(er)
